PJ, 21/28 March 2015, Vol 294, No 7854/5

Pharmacy inspection rankings need an overhaul

The GPhC will scrap the satisfactory rating, but its premises inspection model needs more than a relabel.…

Pharmacists are in a good position to make the move into industry

Pharmacists should value the mix of clinical and scientific knowledge that makes them an asset within industry.…

The secret life of ketamine

Ketamine is being used to treat depression in clinics that are springing up across the United States, but uncertainty remains over its long-term use.…

Prescribing statins: time to rein it in

Statins have been overprescribed for decades for many different reasons. Now is the time to reverse the trend.…

HRT linked with increased stroke risk, conclude Cochrane reviewers

HRT has little if any benefit in the prevention of cardiovascular disease and causes an increase in the risk of stroke and venous thromboembolic events.…

Are membership fees are too high?

As a member of the Royal Pharmaceutical Society (RPS) and the Faculty I have recently renewed my membership at a total cost of £192 plus £75, respectively. The fee is too high and is not comparable to other professions. Although the Royal College of Nursing fee, at £196.35, m…

GP and pharmacy leaders call for pharmacists to work within general practice

A pharmacist should work in every GP practice in England to offer specialist medicines advice and support to patients and take pressure off family doctors.…

Psychosis may have immune-mediated cause, study suggests

A study of children with a first episode of psychosis reveals that a subset produced specific autoantibodies, supporting the involvement of immune-mediated mechanisms.…

Few trial sponsors meet data reporting deadlines

Drug companies and others have an ethical and, increasingly, legal obligation to promptly report results of clinical trials to registers but few meet the reporting deadlines.…

Paroxetine improves symptoms of heart failure in mice

The selective serotonin reuptake inhibitor (SSRI) paroxetine inhibits G-protein-coupled receptor kinase 2, an enzyme that hastens the onset of heart failure.…